THURSDAY, Sept. 12, 2024 (HealthDay News) — Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it forContinue Reading

WEDNESDAY, Sept. 11, 2024 (HealthDay News) — The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid,Continue Reading

MONDAY, Sept. 9, 2024 (HealthDay News) — Losing weight can help a person with obesity — especially those with diabetes — fend off serious infections, new data shows. It’s an important finding, since “up to one in three hospitalizations in people with diabetes are for infections and people with diabetesContinue Reading

FRIDAY, Sept. 6, 2024 (HealthDay News) — PFAS “forever chemicals” could cause pregnant women to experience long-term weight gain, increasing their risk of obesity in middle age, a new study warns. Women with higher levels of PFAS in their blood during early pregnancy weighed more at the age of 50Continue Reading